Form DEF 14A Fortress Biotech, Inc. For: May 23 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The Dow Jones index closed higher by over 475 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Pharmaceutical company Journey Medical Corp. (DERM) announced Friday that the Company has submitted a New Drug Application or NDA, to the U.S. Food and Drug Administration or FDA, seeking approval for DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) for the treatment of inflammatory lesions and erythema of rosacea in adults.
Journey Medical Corp. (DERM) reported positive topline results from the two Phase 3 double-blind, parallel-group, active-comparator and placebo-controlled clinical trials, Minocycline Versus Oracea in Rosacea-1 or MVOR-1 and Minocycline Versus Oracea in Rosacea-2 or MVOR-2, evaluating Minocycline Hydrochloride Modified Release Capsules, 40 mg for the treatment of moderate-to-severe papulopustular rosacea in adults.